3
Disclosures
Feb 4, 2026 — Mar 11, 2026
Date Range
GROWTH
Market Segment

Disclosures

DateTypeHeadlinePDF
Mar 11 Equity Issuance Issues 1,712 Stock Warrants PDF
Mar 11 Forecast FY2026/3 Full-Year Earnings Forecast Downward Revision PDF
Mar 9 Other Renascience Inc. Secures Funding for Lung Cancer Trial; Aims to Enhance Treatment Efficacy PDF

Disclosure Types

Equity Issuance: 1 Forecast: 1 Other: 1